1. Home
  2. SRRK vs GOLF Comparison

SRRK vs GOLF Comparison

Compare SRRK & GOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$40.03

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Logo Acushnet Holdings Corp.

GOLF

Acushnet Holdings Corp.

HOLD

Current Price

$93.27

Market Cap

4.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
GOLF
Founded
2012
1910
Country
United States
United States
Employees
289
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.9B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
SRRK
GOLF
Price
$40.03
$93.27
Analyst Decision
Strong Buy
Hold
Analyst Count
11
7
Target Price
$55.10
$83.67
AVG Volume (30 Days)
1.1M
364.9K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
1.10%
EPS Growth
N/A
N/A
EPS
N/A
3.11
Revenue
N/A
$1,633,721,000.00
Revenue This Year
N/A
$5.01
Revenue Next Year
$449.79
$3.57
P/E Ratio
N/A
$29.88
Revenue Growth
N/A
4.71
52 Week Low
$22.71
$55.31
52 Week High
$49.82
$104.81

Technical Indicators

Market Signals
Indicator
SRRK
GOLF
Relative Strength Index (RSI) 32.95 37.65
Support Level $29.32 $78.60
Resistance Level $42.54 $104.16
Average True Range (ATR) 2.24 3.18
MACD -0.62 -1.15
Stochastic Oscillator 1.77 19.54

Price Performance

Historical Comparison
SRRK
GOLF

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.

Share on Social Networks: